ZBNA
ANIK icon

Zions Bancorporation, National Association’s Anika Therapeutics ANIK Stock Holding History

Zions Bancorporation, National Association’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27K Hold
155
– – ﹤0.01% 1274
2026
Q1 		$2.25K Buy
155
+28
+22% +$325 ﹤0.01% 1184
2025
Q4 		$1.22K Buy
+127
New +$1.22K ﹤0.01% 1052

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.77B AUM
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Zions Bancorporation, National Association's ANIK Position: Q2 2026 in Review

Zions Bancorporation, National Association held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 155 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Zions Bancorporation, National Association first reported a position in ANIK in Q4 2025 and has held it in 3 quarters since. 43 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Zions Bancorporation, National Association held 155 shares of Anika Therapeutics worth $2.27K as of Q2 2026.
  • Zions Bancorporation, National Association left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1274 holding.
  • Zions Bancorporation, National Association first reported a position in Anika Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 43 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.